Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.26
+0.89 (6.19%)
Feb 26, 2026, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.68 billion as of February 27, 2026. Its market cap has increased by 558.15% in one year.
Market Cap
1.68B
Enterprise Value
1.34B
1-Year Change
558.15%
Ranking
Category
Stock Price
$15.26
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.68B, an increase of 56.74%. That is a compound annual growth rate of 11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.58B | 18.96% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 2.25B |
| Bausch Health Companies | 2.24B |
| Harrow | 1.95B |
| BioCryst Pharmaceuticals | 1.94B |
| Perrigo Company | 1.89B |
| ANI Pharmaceuticals | 1.60B |
| Collegium Pharmaceutical | 1.40B |
| Alvotech | 1.28B |